EVRENZO (roxadustat) is a prescription medication used to treat anemia caused by chronic kidney disease (CKD) in adult patients. It belongs to a class of drugs known as hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PH inhibitors). EVRENZO works by stimulating the body's natural production of erythropoietin, a hormone that is essential for the production of red blood cells. By increasing red blood cell production, EVRENZO helps to alleviate the symptoms of anemia, such as fatigue and weakness, improving the quality of life for patients with CKD. This medication is taken orally and is available in tablet form. It is important for patients to follow their healthcare provider's instructions when taking EVRENZO and to discuss any potential side effects or interactions with other medications.